IFNG and neoplasm: AC484 enhances antitumor immunity through multiple mechanisms: increasing tumor sensitivity to IFN‐γ, improving T‐cell functions, stimulating tumor microenvironment inflammation, expanding TCR diversity, and preventing T‐cell exhaustion.